| Literature DB >> 30700746 |
Flavio Vasella1,2, Julia Velz1,2, Marian C Neidert1,2, Stephanie Henzi1,2, Johannes Sarnthein1,2, Niklaus Krayenbühl1,2, Oliver Bozinov1,2, Luca Regli1,2, Martin N Stienen3,4.
Abstract
The aim of the present study was to assess the safety of microsurgical resection of intracranial tumors performed by supervised neurosurgical residents. We analyzed prospectively collected data from our institutional patient registry and dichotomized between procedures performed by supervised neurosurgery residents (defined as teaching procedures) or board-certified faculty neurosurgeons (defined as non-teaching procedures). The primary endpoint was morbidity at discharge, defined as a postoperative decrease of ≥10 points on the Karnofsky Performance Scale (KPS). Secondary endpoints included 3-month (M3) morbidity, mortality, the in-hospital complication rate, and complication type and severity. Of 1,446 consecutive procedures, 221 (15.3%) were teaching procedures. Patients in the teaching group were as likely as patients in the non-teaching group to experience discharge morbidity in both uni- (OR 0.85, 95%CI 0.60-1.22, p = 0.391) and multivariate analysis (adjusted OR 1.08, 95%CI 0.74-1.58, p = 0.680). The results were consistent at time of the M3 follow-up and in subgroup analyses. In-hospital mortality was equally low (0.24 vs. 0%, p = 0.461) and the likelihood (p = 0.499), type (p = 0.581) and severity of complications (p = 0.373) were similar. These results suggest that microsurgical resection of carefully selected intracranial tumors can be performed safely by supervised neurosurgical residents without increasing the risk of morbidity, mortality or perioperative complications. Appropriate allocation of operations according to case complexity and the resident's experience level, however, appears essential.Entities:
Mesh:
Year: 2019 PMID: 30700746 PMCID: PMC6353994 DOI: 10.1038/s41598-018-37533-3
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Study algorithm, demonstrating how the final study cohort was arrived at and followed until the 3-month appointment (M3).
Baseline patient demographics.
| Teaching procedure | Non-teaching procedure | p-value | |
|---|---|---|---|
| Age (in years) | 59.3 (14.8) | 53.4 (17.6) | <0.001 |
| Sex | |||
| Male | 111 (50.2%) | 598 (48.8%) | 0.700 |
| Female | 110 (49.8%) | 627 (51.2%) | |
| ASA class | |||
| 1 | 12 (5.4%) | 131 (10.7%) | 0.002 |
| 2 | 110 (49.8%) | 684 (55.8%) | |
| 3 | 94 (42.5%) | 376 (30.7%) | |
| 4 | 5 (2.3%) | 34 (2.8%) | |
| Smoking status | |||
| Nonsmoker | 128 (57.9%) | 735 (60.0%) | 0.801 |
| Active smoker | 53 (24.0%) | 288 (23.5%) | |
| Former smoker | 40 (18.1%) | 202 (16.5%) | |
| Weight (in kg)* | 75.7 (17.2) | 74.3 (19.3) | 0.559 |
| Previous surgery | |||
| Yes | 33 (14.9%) | 274 (22.4%) | 0.013 |
| No | 188 (85.1%) | 951 (77.6%) | |
| Type of tumor | |||
| Intraaxial | 143 (64.7%) | 799 (65.2%) | 0.550 |
| Extraaxial | 73 (33.0%) | 410 (33.5%) | |
| Unspecified | 5 (2.3%) | 16 (1.3%) | |
| Histopathology | |||
| (Epi-)dermoid | 2 (0.9%) | 16 (1.3%) | <0.001 |
| Anapl. Astrocytoma | 5 (2.2%) | 89 (7.3%) | |
| Glioblastoma | 66 (29.9%) | 251 (20.5%) | |
| Low grade glioma | 11 (5.0%) | 144 (11.7%) | |
| Meningioma | 42 (19.0%) | 344 (28.1%) | |
| Metastasis | 73 (33.0%) | 219 (17.9%) | |
| Schwannoma | 3 (1.4%) | 73 (5.9%) | |
| Other | 19 (8.6%) | 89 (7.3%) | |
| Admission KPS | |||
| Good (80–100) | 159 (72.0%) | 929 (75.8%) | 0.386 |
| Moderate (50–70) | 53 (24.0%) | 261 (21.3%) | |
| Poor (40–0) | 9 (4.0%) | 35 (2.9%) | |
| Admission mRS | |||
| Good (0–1) | 113 (51.1%) | 694 (56.7%) | 0.314 |
| Moderate (2–3) | 96 (43.5%) | 471 (38.5%) | |
| Poor (4–5) | 12 (5.4%) | 60 (4.9%) | |
| Admission NIHSS | |||
| 0–1 | 148 (67.0%) | 844 (68.9%) | 0.663 |
| 2–5 | 64 (29.0%) | 322 (26.3%) | |
| ≥6 | 9 (4.0%) | 59 (4.8%) | |
| Tumor size (cm) | 3.80 (1.81) | 3.72 (1.86) | 0.607 |
| Milan Complexity Score | |||
| Low complexity (0–2) | 126 (57.0%) | 473 (38.6%) | <0.001 |
| Moderate complexity (3–5) | 90 (40.7%) | 545 (44.5%) | |
| High complexity (6–8) | 5 (2.3%) | 207 (16.9%) | |
| n = 221 (100%) | n = 1,225 (100%) | ||
Data is presented in mean (standard deviation) or count (percent). *Indicates an incomplete dataset.
Relationship between teaching procedure and discharge morbidity.
| Discharge morbidity | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
| OR | 95% CI | p-value | OR | 95% CI | p-value | |
| Teaching procedure | 0.85 | 0.60–1.22 | 0.391 | 1.08 | 0.74–1.58 | 0.680 |
| Age ≥ 56 years | 1.01 | 0.79–1.30 | 0.933 | 1.28 | 0.96–1.70 | 0.098 |
| ASA grade (per 1-step increase) | 0.89 | 0.74–1.08 | 0.230 | 0.89 | 0.72–1.09 | 0.259 |
| Primary surgery | 0.92 | 0.68–1.24 | 0.580 | 0.90 | 0.66–1.23 | 0.510 |
| MCS grade (per increase in category) | 1.80 | 1.50–2.15 | <0.001* | 1.80 | 1.49–2.17 | <0.001* |
| Metastasis | 0.60 | 0.43–0.85 | 0.004 | 0.60 | 0.39–0.92 | 0.020 |
| Glioblastoma | 1.24 | 0.93–1.66 | 0.148 | 1.00 | 0.69–1.45 | 0.997 |
| Meningioma | 0.74 | 0.55–1.00 | 0.051 | 0.62 | 0.44–0.88 | 0.007 |
Uni- and multivariate logistic regression analysis estimating the relationship between teaching procedure and worsening on the Karnofsky Performance Scale (KPS) by ≥10 points at time of discharge. The multivariate analysis is adjusted for baseline differences in age (stratified by the median), American Society of Anesthesiology (ASA) grading scale, primary surgery, procedure complexity (Milan Complexity Score; MCS) and the most common histopathological subtypes. *Significant after Bonferroni correction for multiple testing.
Relationship between teaching procedure and 3-month morbidity.
| 3-month morbidity | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
| OR | 95% CI | p-value | OR | 95% CI | p-value | |
| Teaching procedure | 1.16 | 0.83–1.62 | 0.376 | 1.03 | 0.72–1.47 | 0.887 |
| Age ≥ 56 years | 1.59 | 1.24–2.04 | <0.001* | 1.31 | 0.98–1.75 | 0.063 |
| ASA grade (per 1-step increase) | 1.47 | 1.22–1.77 | <0.001* | 1.15 | 0.94–1.40 | 0.188 |
| Primary surgery | 0.78 | 0.58–1.04 | 0.085 | 0.69 | 0.51–0.94 | 0.020 |
| MCS grade (per increase in category) | 1.35 | 1.13–1.60 | 0.001* | 1.68 | 1.38–2.04 | <0.001* |
| Metastasis | 1.71 | 1.28–2.27 | <0.001* | 2.19 | 1.48–3.26 | <0.001* |
| Glioblastoma | 2.43 | 1.85–3.18 | <0.001* | 2.65 | 1.83–3.82 | <0.001* |
| Meningioma | 0.33 | 0.24–0.47 | <0.001* | 0.56 | 0.37–0.85 | 0.006 |
Uni- and multivariate logistic regression analysis estimating the relationship between teaching procedure and worsening on the Karnofsky Performance Scale (KPS) by ≥10 points at time of 3-month follow-up. The multivariate analysis is adjusted for baseline differences in age (stratified by the median), American Society of Anesthesiology (ASA) grading scale, primary surgery, procedure complexity (Milan Complexity Score; MCS) and the most common histopathological subtypes. *Significant after Bonferroni correction for multiple testing.
Relationship between teaching procedure and 3-month mortality.
| 3-month mortality | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
| OR | 95% CI | p-value | OR | 95% CI | p-value | |
| Teaching procedure | 2.82 | 1.64–4.84 | <0.001* | 1.82 | 1.01–3.26 | 0.044 |
| Age ≥ 56 years | 3.24 | 1.80–5.83 | <0.001* | 1.54 | 0.81–2.93 | 0.185 |
| ASA grade (per 1-step increase) | 4.05 | 2.74–6.00 | <0.001* | 2.88 | 1.86–4.47 | <0.001* |
| Primary surgery | 0.89 | 0.49–1.61 | 0.710 | 0.64 | 0.34–1.20 | 0.164 |
| MCS grade (per increase in category) | 0.69 | 0.47–1.00 | 0.056 | 0.91 | 0.57–1.45 | 0.692 |
| Metastasis | 7.17 | 4.27–12.0 | <0.001* | 6.09 | 2.36–15.7 | <0.001* |
| Glioblastoma | 1.50 | 0.87–2.60 | 0.148 | 2.77 | 1.04–7.39 | 0.041 |
| Meningioma+ | — | — | — | — | — | — |
Uni- and multivariate logistic regression analysis estimating the relationship between teaching procedure and 3-month mortality. The multivariate analysis is adjusted for baseline differences in age (stratified by the median), American Society of Anesthesiology (ASA) grading scale, primary surgery, procedure complexity (Milan Complexity Score; MCS) and the most common histopathological subtypes.* Significant after Bonferroni correction for multiple testing. +386 observations with meningioma eliminated from analysis, as no 3-month mortality occured in meningioma patients.
Rate and classification of in-hospital complications.
| Teaching procedure | Non-teaching procedure | p-value | |
|---|---|---|---|
| Any complication | |||
| No | 173 (78.3%) | 856 (69.9%) | 0.011 |
| Yes | 48 (21.7%) | 369 (30.1%) | |
| Complication severity (CDG) | |||
| 1 | 19 (39.6%) | 187 (50.7%) | 0.373 |
| 2 | 19 (39.6%) | 131 (35.5%) | |
| 3a | 3 (6.2%) | 12 (3.3%) | |
| 3b | 6 (12.5%) | 23 (6.2%) | |
| 4a | 1 (2.1%) | 13 (3.5%) | |
| 4b | −(0%) | −(0%) | |
| 5 | −(0%) | 3 (0.8%) | |
| n = 221 (100%) | n = 1225 (100%) | ||
Therapy-oriented severity classification of complications according to the Clavien-Dindo grading scale (CDG).
Rate and etiology of in-hospital complications.
| Teaching procedure | Non-teaching procedure | p-value | |
|---|---|---|---|
| CSF-related | 2 (4.2%) | 15 (4.1%) | 0.581 |
| Epilepsy | 6 (12.5%) | 27 (7.3%) | |
| General medicine | 15 (31.3%) | 85 (23.0%) | |
| Hemorrhagic | 2 (4.2%) | 26 (7.1%) | |
| Ischemic | 4 (8.3%) | 38 (10.3%) | |
| Septic | −(0.0%) | 6 (1.6%) | |
| Traumatic | 16 (33.3%) | 158 (42.8%) | |
| Other | 3 (6.2%) | 14 (3.8%) | |
| n = 48 (100%) | n = 369 (100%) |
Etiology of in-hospital complications classified according to Ferroli et al.[11].
Extent of resection.
| EOR | Teaching procedure | Non-teaching procedure | p-value |
|---|---|---|---|
| Gross total resection | 83 (37.5%) | 426 (34.8%) | 0.158 |
| Subtotal resection | 63 (28.5%) | 434 (35.5%) | |
| Unclear | 62 (28.1%) | 282 (23.0%) | |
| No imaging available | 13 (5.9%) | 82 (6.7%) | |
| n = 221 (100%) | n = 1224 (100%) |
Extent of resection (EOR), as judged by postoperative magnetic resonance imaging.